We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Paper in leading Journal

30 Nov 2018 07:00

RNS Number : 9782I
DeepMatter Group PLC
30 November 2018
 

30 November 2018

DeepMatter Group plc

("DeepMatter", or the "Group")

 

Publication of Paper in Science

 

DeepMatter, the AIM-listed company focusing on digitizing chemistry, announces that its founding scientific director, Professor Lee Cronin, and his colleagues at the University of Glasgow have today published a paper in Science, a leading international journal. DeepMatter has rights to intellectual property arising from the laboratory of Professor Cronin as part of its Intellectual Property and Royalty agreement with the University of Glasgow.

 

The paper describes for the first time a method of molecule production which uses downloadable 'blueprints' to easily and reliably synthesise chemicals, such as drug molecules, automatically via a programmable chemical-robot: a 'Chemputer'. The idea of the 'Chemputer' is underpinned by a universal and interoperable standard for writing and sharing chemical recipes, developed by the University of Glasgow team. A number of the scientific concepts detailed in this paper make up a critical part of DeepMatter's commercial strategy.

 

DeepMatter has used its own universal and interoperable standard for writing and sharing chemical recipes as part of its DigitalGlassware™ platform. Currently, the platform allows experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. It is designed to enable scientists to work together effectively, sharing the details of their experiments in real time from anywhere so that work is not needlessly duplicated, time and money wasted, and ultimately so that new discoveries may be made faster.

 

DeepMatter's long term goal is to use DigitalGlassware™ to control robotics and to ultimately progress towards a commercially viable Chemputer™. In 2017, as part of its strategy to build its commercial market presence for the digitization of chemistry, DeepMatter registered the trademark for the Chemputer™ brand.

 

The full scientific Paper, 'Organic synthesis in a modular robotic system driven by a chemical programming language' can be found at www.sciencemag.org

 

Mark Warne, CEO of DeepMatter, commented:

 

"We are very pleased to see the work of our founding scientific director published in Science today. The recognition of such an esteemed publication demonstrates the significance of both the University of Glasgow's important research and our work here at DeepMatter, translating these advances into a commercially viable strategy.

 

"We believe that these developments can truly disrupt the way in which process and discovery chemistry is carried out today, bringing huge financial benefits to those working in these industries. We are very pleased to have the first stage of the DigitalGlasswareTM launch underway and look forward to continuing to educate chemists worldwide as to the benefits of using the platform."

 

For further information:

 

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

 

Stockdale Securities Limited

 

T: 020 7601 6100

Tom Griffiths

Edward Thomas

 

 

 

Alma PR

Caroline Forde

Rebecca Sanders-Hewett

Susie Hudson

 

T: 020 3405 0209

deepmatter@almapr.co.uk

 

About DeepMatter:

 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors.

 

The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

 

More information is available here: http://www.deepmattergroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPFNAELPFFF
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.